Akari Therapeutics ADR
(AKTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13,391 | 3,792 | 6,668 | 14,056 | 12,318 |
| Other current assets | 1,304 | 1,012 | 1,145 | 522 | 1,349 |
| TOTAL | $14,695 | $4,804 | $7,813 | $14,578 | $13,667 |
| Non-Current Assets | |||||
| Intangibles | 0 | 26 | 0 | 27 | 27 |
| Other Non-Current Assets | 24 | 0 | 27 | 0 | 0 |
| TOTAL | $24 | $26 | $27 | $27 | $27 |
| Total Assets | $14,719 | $4,830 | $7,840 | $14,605 | $13,694 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,923 | 1,685 | 2,832 | 3,381 | 2,411 |
| Accrued Expenses | 1,433 | 1,557 | 1,071 | 1,840 | 976 |
| Other current liabilities | N/A | N/A | N/A | N/A | 5,449 |
| TOTAL | $3,356 | $3,242 | $3,903 | $5,221 | $8,835 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $3,356 | $3,242 | $3,903 | $5,221 | $8,835 |
| Shareholders' Equity | |||||
| Common Shares | 476 | 397 | 385 | 385 | 46,579 |
| Retained earnings | -193,917 | -192,466 | -188,119 | -182,281 | -154,169 |
| Other shareholders' equity | 51,746 | 51,774 | 51,852 | 51,546 | -621 |
| TOTAL | $11,363 | $1,588 | $3,937 | $9,384 | $4,858 |
| Total Liabilities And Equity | $14,719 | $4,830 | $7,840 | $14,605 | $13,694 |